Loading...
•
Jun 30, 2023
Bausch Health Q2 2023 Earnings Report
Bausch Health announced second-quarter 2023 results, raised full-year 2023 revenue outlook, and provided other key updates from the quarter.
Key Takeaways
Bausch Health reported a strong second quarter with revenue of $2.17 billion, up 10% reported and 11% organic. GAAP net income attributable to Bausch Health Companies Inc. was $26 million, and adjusted EBITDA was $727 million, up 4%. The company raised its full-year revenue outlook and reaffirmed its adjusted EBITDA guidance.
Favorable Motion Ruling in Xifaxan® Litigation Reinforces Continuing Salix Growth Strategy
Balance Sheet Initiatives Further Enhance Liquidity Profile
Continued Evaluation of Optimal Implementation of Potential Bausch + Lomb Distribution
Revenue of $2.17 billion, Up 10% Reported and 11% Organic
Bausch Health
Bausch Health
Bausch Health Revenue by Segment
Revenue by Segment
Bausch + Lomb/International Revenue
CapyFin.comSalix Revenue
CapyFin.comDiversified Products Revenue
CapyFin.com Forward Guidance
The Company increased its full year revenue guidance and reaffirmed its Adjusted EBITDA1 guidance for Total Bausch Health
Revenue & Expenses
Visualization of income flow from segment revenue to net income